Reducing medication-related harm (MRH) in older adults within 8 weeks post-discharge from the hospital Other
Conditions
Interventions
Participants will undergo simple randomization into the two arms: a control arm and an intervention arm.
Participants in the control arm will receive the existing NHS Discharge Medicines Service, whe
Sponsors
University of Sussex
Eligibility
Sex/Gender
All
Age
65 Years to 120 Years
Inclusion criteria
Inclusion criteria: 1. Patients must be over the age of 65 years at the time of recruitment, admitted to an acute Elderly Care or General Medical Ward 2. Patients to be identified when they are likely to be discharged within 48 hours 3. Patients need to be registered with a General Practitioner within the areas covered by the recruiting hospitals 4. Informed written consent must be provided from patients with capacity OR personal consultees acting on behalf of patients without capacity
Exclusion criteria
Exclusion criteria: 1. Patients lacking capacity and have no consultee to advise 2. Patients that are transferred to other acute healthcare trusts (but excluding step down or intermediate care facilities) 3. Patients who have a short life expectancy, due to a terminal illness 4. Patients who are unable to read/speak/understand English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of participants that had medication-related harm who had only the NHS-discharge medicines services (DMS) and the number of participants with medication-related harm who had both the NHS-DMS with the medicines management plan (MMP), measured using a phone interview at the end of the 8-week period | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The acceptability of the control and intervention arm among clinicians, service providers, researchers and other health workers involved in discharge planning assessed through focus group interviews during the study period 2. The cost-effectiveness of the intervention will be measured using economic analysis estimating the resources involved in delivering the intervention and treatment of medication-related harm within 8 weeks post-discharge | — |
Countries
England, United Kingdom
Outcome results
None listed